AirSculpt Technologies (NASDAQ:AIRS) Releases Quarterly Earnings Results, Misses Expectations By $0.01 EPS

AirSculpt Technologies (NASDAQ:AIRS) released its quarterly earnings data on Monday. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.02 by ($0.01), FiscalAI reports. The business had revenue of $42.90 million during the quarter, compared to the consensus estimate of $44.14 million. AirSculpt Technologies had a negative return on equity of 4.98% and a negative net margin of 7.39%.

AirSculpt Technologies Stock Performance

Shares of AIRS stock opened at $5.01 on Monday. The stock has a market capitalization of $353.46 million, a PE ratio of -29.47 and a beta of 2.33. AirSculpt Technologies has a 1-year low of $1.51 and a 1-year high of $12.00. The business has a 50-day moving average of $4.74 and a 200 day moving average of $3.56. The company has a debt-to-equity ratio of 0.39, a current ratio of 0.75 and a quick ratio of 0.75.

Institutional Trading of AirSculpt Technologies

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Balyasny Asset Management L.P. boosted its stake in shares of AirSculpt Technologies by 128.5% during the second quarter. Balyasny Asset Management L.P. now owns 1,113,843 shares of the company’s stock valued at $5,380,000 after purchasing an additional 626,309 shares during the period. Renaissance Technologies LLC bought a new stake in AirSculpt Technologies during the 4th quarter valued at $1,991,000. Vanguard Group Inc. raised its holdings in AirSculpt Technologies by 10.8% during the 3rd quarter. Vanguard Group Inc. now owns 782,543 shares of the company’s stock valued at $6,276,000 after buying an additional 76,291 shares during the last quarter. Geode Capital Management LLC boosted its position in AirSculpt Technologies by 4.6% during the 4th quarter. Geode Capital Management LLC now owns 403,163 shares of the company’s stock valued at $798,000 after buying an additional 17,889 shares during the period. Finally, Saba Capital Management L.P. purchased a new stake in AirSculpt Technologies during the 4th quarter valued at $620,000. Institutional investors own 91.54% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on AIRS. Wall Street Zen upgraded AirSculpt Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th. Leerink Partners set a $4.50 target price on AirSculpt Technologies in a report on Thursday, May 14th. Finally, Weiss Ratings upgraded shares of AirSculpt Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, July 1st. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus price target of $4.50.

AirSculpt Technologies Company Profile

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.